Trial Profile
Phase II open-label study of volociximab in combination with DTIC in patients with metastatic melanoma not previously treated with chemo
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2007
Price :
$35
*
At a glance
- Drugs Dacarbazine (Primary) ; Volociximab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Sep 2007 Status change from in progress to completed
- 19 Sep 2005 New trial record.